BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31675694)

  • 1. Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage.
    Aida Y; Kamide T; Ishii H; Kitao Y; Uchiyama N; Nakada M; Hori O
    J Neurosurg; 2019 Nov; 134(1):122-130. PubMed ID: 31675694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant soluble form of receptor for advanced glycation end products ameliorates microcirculation impairment and neuroinflammation after subarachnoid hemorrhage.
    Yang LY; Tang SC; Lee JE; Chen YR; Chen YT; Chen KW; Hsieh ST; Wang KC
    Neurotherapeutics; 2024 Mar; 21(2):e00312. PubMed ID: 38177024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage.
    Sokół B; Wąsik N; Jankowski R; Hołysz M; Mańko W; Juszkat R; Małkiewicz T; Jagodziński PP
    Biomed Res Int; 2017; 2017():7931534. PubMed ID: 28630869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage.
    Li H; Wu W; Sun Q; Liu M; Li W; Zhang XS; Zhou ML; Hang CH
    Brain Res; 2014 Jan; 1543():315-23. PubMed ID: 24291745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage.
    Li H; Yu JS; Zhang DD; Yang YQ; Huang LT; Yu Z; Chen RD; Yang HK; Hang CH
    Mol Neurobiol; 2017 Jan; 54(1):755-767. PubMed ID: 26768594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
    Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
    Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
    Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
    Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
    Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
    Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
    Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
    Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
    J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Tsirebolos G; Tsoporis JN; Drosatos IA; Izhar S; Gkavogiannakis N; Sakadakis E; Triantafyllis AS; Parker TG; Rallidis LS; Rizos I
    Int J Cardiol; 2023 Apr; 376():127-133. PubMed ID: 36758863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome.
    Steenbeke M; De Bruyne S; De Buyzere M; Lapauw B; Speeckaert R; Petrovic M; Delanghe JR; Speeckaert MM
    Crit Rev Clin Lab Sci; 2021 Mar; 58(2):113-130. PubMed ID: 32669010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
    Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.